| Literature DB >> 32804442 |
Amitabh Das1,2, Xiaobei Wang1,2, Jessica Kang1, Alyssa Coulter2, Amol C Shetty3, Mahesh Bachu4,5, Stephen R Brooks6, Stefania Dell'Orso6, Brian L Foster7, Xiaoxuan Fan8, Keiko Ozato4, Martha J Somerman2, Vivek Thumbigere-Math1,2.
Abstract
Osteoclasts (OCs) are bone-resorbing cells formed by the serial fusion of monocytes. In mice and humans, three distinct subsets of monocytes exist; however, it is unclear if all of them exhibit osteoclastogenic potential. Here we show that in wild-type (WT) mice, Ly6Chi and Ly6Cint monocytes are the primary source of OC formation when compared to Ly6C- monocytes. Their osteoclastogenic potential is dictated by increased expression of signaling receptors and activation of preestablished transcripts, as well as de novo gain in enhancer activity and promoter changes. In the absence of interferon regulatory factor 8 (IRF8), a transcription factor important for myelopoiesis and osteoclastogenesis, all three monocyte subsets are programmed to display higher osteoclastogenic potential. Enhanced NFATc1 nuclear translocation and amplified transcriptomic and epigenetic changes initiated at early developmental stages direct the increased osteoclastogenesis in Irf8-deficient mice. Collectively, our study provides novel insights into the transcription factors and active cis-regulatory elements that regulate OC differentiation.Entities:
Keywords: BONE MARROW; ChIP-seq; IRF8; LY6C; MACROPHAGE; MONOCYTE; OSTEOCLAST; RANK; RANKL; RNA-seq
Mesh:
Substances:
Year: 2020 PMID: 32804442 PMCID: PMC8168257 DOI: 10.1002/jbmr.4165
Source DB: PubMed Journal: J Bone Miner Res ISSN: 0884-0431 Impact factor: 6.741